Two vaccines hit snags as Pfizer nears US approval

Two vaccine candidates stumbled Friday in the race among researchers to combat COVID-19, a setback for the global immunisation effort even as the Pfizer-BioNTech jab neared approval in the US. The mixed news on the vaccine front comes as infections accelerated fast in North America and parts of Africa but started to stabilise in Europe and drop in Asia and […]
Continue reading »